XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Equity Offering [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Previously Reported [Member]
Common Stock [Member]
Common Stock [Member]
Equity Offering [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Equity Offering [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings (Accumulated Deficit) [Member]
Retained Earnings (Accumulated Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings (Accumulated Deficit) [Member]
Previously Reported [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Previously Reported [Member]
Beginning Balance at Dec. 30, 2017     $ 1,883 $ 175,325     $ 525     $ 252,275     $ 1,883 $ (64,716)   $ (12,759)
Begining Balance, Shares at Dec. 30, 2017             49,805,338                  
Beginning Balance at Dec. 30, 2017 $ 177,208       $ 525     $ 252,275       $ (62,833)     $ (12,759)  
Beginning Balance, Shares at Dec. 30, 2017         49,805,338                      
Beginning Balance at Dec. 30, 2017     $ 1,883 $ 175,325     $ 525     $ 252,275     $ 1,883 $ (64,716)   $ (12,759)
Begining Balance, Shares at Dec. 30, 2017             49,805,338                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201409Member                              
Beginning Balance at Dec. 30, 2017 $ 177,208       $ 525     252,275       (62,833)     (12,759)  
Beginning Balance, Shares at Dec. 30, 2017         49,805,338                      
Grants of restricted stock         $ 2     (2)                
Vesting of restricted stock, Shares         162,841                      
Forfeitures of restricted stock         $ (1)     1                
Purchases of treasury stock (687)                           (687)  
Purchases of treasury stock, Shares         (35,691)                      
Retirement of treasury stock               (687)             687  
Stock-based compensation 2,796             2,796                
Exercise of stock options $ 2,239       $ 11     2,228                
Exercise of stock options, Shares 1,119,247       1,119,247                      
Common stock issued under equity offering   $ 152,503       $ 70     $ 152,433              
Common stock issued under equity offering, Shares           7,000,000                    
Common stock issued in employee grant $ 587             587                
Common stock issued in employee grant, Shares 28,160       28,160                      
Common stock issued under ESPP $ 30             30                
Common stock issued under ESPP, Shares         1,645                      
Other comprehensive income (loss) (3,065)                   $ (3,065)          
Net income 53,933                     53,933        
Ending Balance at Dec. 29, 2018 385,544       $ 607     409,661     (3,065) (8,900)     (12,759)  
Ending Balance, Shares at Dec. 29, 2018         58,081,540                      
Grants of restricted stock         $ 6     (6)                
Vesting of restricted stock, Shares         164,226                      
Forfeitures of restricted stock         $ (1)     1                
Purchases of treasury stock (6,055)                           (6,055)  
Purchases of treasury stock, Shares         (428,059)                      
Retirement of treasury stock               (505)             505  
Stock-based compensation 3,923             3,923                
Exercise of stock options $ 1,562       $ 7     1,555                
Exercise of stock options, Shares 682,931       682,931                      
Common stock issued under ESPP $ 59             59                
Common stock issued under ESPP, Shares         4,096                      
Other comprehensive income (loss) 2,827                   2,827          
Net income 43,688                     43,688        
Ending Balance at Dec. 28, 2019 431,548       $ 619     414,688     (238) 34,788     (18,309)  
Ending Balance, Shares at Dec. 28, 2019         58,504,734                      
Grants of restricted stock         $ 7     (7)                
Vesting of restricted stock, Shares         219,977                      
Forfeitures of restricted stock         $ (3)     3                
Purchases of treasury stock (815)                           (815)  
Purchases of treasury stock, Shares         (51,479)                      
Retirement of treasury stock         $ (1)     (814)             815  
Stock-based compensation 5,458             5,458                
Exercise of stock options $ 572       $ 3     569                
Exercise of stock options, Shares 284,353       284,353                      
Common stock issued under ESPP $ 305             305                
Common stock issued under ESPP, Shares         41,126                      
Other comprehensive income (loss) 2,958                   2,958          
Net income 45,108                     45,108        
Ending Balance at Jan. 02, 2021 $ 485,134       $ 625     $ 420,202     $ 2,720 $ 79,896     $ (18,309)  
Ending Balance, Shares at Jan. 02, 2021         58,998,711